Prof. Flavio Rizzolio is a molecular biologist affiliated with Ca’ Foscari University of Venice, based in the Department of Molecular Sciences and Nanosystems.

He also holds a senior researcher position at the National Cancer Institute of Aviano. Prof. Rizzolio has spearheaded various national and international research initiatives primarily in the realm of cancer biology and nanomedicine.

His contributions to scientific literature encompass over 150 peer-reviewed scientific articles and groundbreaking findings with potential market applications have been covered by patents. In addition to his academic and research roles, Prof. Rizzolio is the founder and CEO of Biofuture Medicine, a biotechnology firm specializing in cancer-related endeavours. He maintains active collaborations with multiple enterprises specializing in diagnostic medicine.